Long-Term Safety of Tofacitinib for Treatment of Moderate-to-Severe Ulcerative Colitis: Three Years of Korean National Data
Tofacitinib demonstrates a safety profile comparable to that of anti-TNF inhibitors in Korean patients with UC. Despite safety concerns, tofacitinib can be safely used in this population with caution in older patients and those with comorbidities.
Authors
- Gi Hyeon Seo (ORCID: https://orcid.org/0000-0001-7414-0258)
- Eun Mi Song (ORCID: https://orcid.org/0000-0002-2428-1551)
- Sung Hoon Jung (ORCID: https://orcid.org/0000-0001-9075-2027)
Institutions
- Ewha Womans University (KR)
- Health Insurance Review and Assessment Service (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3346/jkms.2025.40.e259
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Korea Health Industry Development Institute